SC 13G Filing

Company

Lyra Therapeutics, Inc.

Filed

November 8, 2022

Accession Number

0001590144-22-000025

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →